Cumulative Intelligent Bio Solutions Inc 's Leverage Ratio for Trailing Twelve Months Period

INBS's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth

Select the Comparisons :

None ▼

Select the Ratio:

Leverage Ratio for Trailing Twelve Months Period ▼

None ▼

Leverage Ratio for Trailing Twelve Months Period ▼

INBS Leverage Ratio for Trailing Twelve Months Period	(Dec 31 2022) II. Quarter	(Sep 30 2022) I. Quarter	(Jun 30 2022) IV. Quarter	(Mar 31 2022) III. Quarter	(Dec 31 2021) II. Quarter
Y / Y Equity Growth	2.17 %	-61.51 %	-	-	-
Y / Y Total Liabilities Growth	49.94 %	-12.09 %	-	-	-
Leverage Ratio for Trailing Twelve Months Period	0.78	0.7	0.57	0.5	0.45
Total Ranking	# 1060	# 1437	# 1323	#	#
Seq. Equity Growth	97.51 %	-20.62 %	-24.79 %	-13.35 %	-25.6 %
Seq. Total Liabilities Growth	57.7 %	-14.82 %	2.52 %	8.88 %	-7.55 %

INBS Segments >> More on INBS Financial Strength Comparisons >> See INBS Balance Sheets

Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022

On the trailing twelve months basis Due to net new borrowings of 57.7%, Leverage Ratio for Trailing Twelve Months Period improved to 0.78, above Intelligent Bio Solutions Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 68 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Intelligent Bio Solutions Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are INBS's Customers?

Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within:	No.
Industry	# 69
Sector	# 390
S&P 500	# 1009

Leverage Ratio for Trailing Twelve Months Period Statistics
High	Average	Low
0.79	0.69	0.57
(Dec 31 2022)		(Jun 30 2022)

Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Medical Equipment & Supplies Industry	Leverage Ratio for Trailing Twelve Months Period
Minerva Surgical Inc	2.12
3m Company	2.09
Cerus Corporation	1.93
Patterson Companies Inc	1.65
Uphealth Inc	1.63
Conmed Corporation	1.58
Artivion Inc	1.57
U S Physical Therapy Inc	1.57
Novocure Limited	1.53
Nuvasive Inc	1.51
Biolase Inc	1.49
Haemonetics Corporation	1.39
Carlisle Companies Incorporated	1.39
Viewray Inc	1.35
Dexcom Inc	1.35
Apollo Endosurgery inc	1.35
Pear Therapeutics Inc	1.30
Neuropace Inc	1.29
Stryker Corp	1.28
Tandem Diabetes Care Inc	1.26
Iridex Corp	1.25
Viveve Medical Inc	1.22
Bioventus Inc	1.19
Ekimas Corporation	1.14
Plus Therapeutics Inc	1.14
Strata Skin Sciences Inc	1.13
Integra Lifesciences Holdings Corp	1.12
Star Equity Holdings Inc	1.11
Sharps Technology Inc.	1.08
Infusystem Holdings Inc	1.07


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar SMBC's Profile Stock Price SMBC's Financials Business Description Fundamentals Charts & Quotes SMBC's News Suppliers SMBC's Competitors Customers & Markets Economic Indicators SMBC's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

Cumulative Intelligent Bio Solutions Inc 's Leverage Ratio for Trailing Twelve Months Period

INBS Leverage Ratio for Trailing Twelve Months Period